Cristina Oliva - Publications, H-index & Citations

Cristina Oliva

harvard university medical affiliates

31H指数

115论文数

9.8K被引数

收录论文 27

发表时间

Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial Bemcentinib作为单药治疗以及与低剂量阿糖胞苷联合治疗不适合接受强化疗的急性髓系白血病患者：一项1b/2a期临床试验

NATURE COMMUNICATIONS

IF15.7

2025-03-23

OAAI

Loges, Sonja; Heuser, Michael; Chromik, Joerg; Sutamtewagul, Grerk; Kapp-Schwoerer, Silke; Crugnola, Monica; Di Renzo, Nicola; Lemoli, Roberto; Mattei, Daniele; Fiedler, Walter; Alvarado-Valero, Yesid; Ben-Batalla, Isabel; Waizenegger, Jonas; Rieckmann, Lisa-Marie; Janning, Melanie; Collienne, Maike; Imbusch, Charles D.; Beumer, Niklas; Micklem, David; Nilsson, Linn; Madeleine, Noelly; Mccracken, Nigel; Oliva, Cristina; Gorcea-Carson, Claudia; Gjertsen, Bjorn T.

An unintended consequence of COVID-19 immunity passports-quasi-experimental evidence of moral hazard observed after implementing the domestic Green Pass policy during the second wave of the COVID-19 pandemic in Italy 新型冠状病毒肺炎豁免护照的意外后果-在意大利第二波新型冠状病毒肺炎大流行期间实施国内绿色通行证政策后观察到的道德风险的准实验证据

FRONTIERS IN PUBLIC HEALTH

IF3.4

2024-04-17

OAAI

Oliva, Cristina

From 15 Minutes to 15 Seconds: How the Delta Variant Changed the Risk of Exposure to COVID-19. A Comparative Epidemiological Investigation Using Community Mobility Data From the Metropolitan Area of Genoa, Italy

FRONTIERS IN PUBLIC HEALTH

IF3.4

2022-07-05

OAAI

Oliva, Cristina; Favato, Giampiero

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective

ESMO OPEN

IF8.3

2022-02-01

OAAI

Sessa, C.; Cortes, J.; Conte, P.; Cardoso, F.; Choueiri, T.; Dummer, R.; Lorusso, P.; Ottmann, O.; Ryll, B.; Mok, T.; Tempero, M.; Comis, S.; Oliva, C.; Peters, S.; Tabernero, J.

Cross-regional variations of Covid-19 mortality in Italy: an ecological study

JOURNAL OF PUBLIC HEALTH

IF3.1

2021-01-18

OAAI

Oliva, Cristina; Di Maddaloni, Francesco; Marcellusi, Andrea; Favato, Giampiero

TRIAL WATCH Combinations take centre stage in PD1/PDL1 inhibitor clinical trials

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2020-11-11

119

PREAI

Upadhaya, Samik; Neftelino, Svetoslav T.; Hodge, Jeffrey P.; Oliva, Cristina; Campbell, Jay R.; Yu, Jia Xin

Impact of COVID-19 on oncology clinical trials

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2020-05-18

OAAI

Upadhaya, Samik; Yu, Jia Xin; Oliva, Cristina; Hooton, Megan; Hodge, Jeffrey; Hubbard-Lucey, Vanessa M.

Trends in clinical development for PD-1/PD-L1 inhibitors PD-1/PD-L1抑制剂的临床发展趋势

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2019-11-04

183

PREAI

Yu, Jia Xin; Hodge, Jeffrey P.; Oliva, Cristina; Neftelinov, Svetoslav T.; Hubbard-Lucey, Vanessa M.; Tang, Jun

Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2014-05-22

OAAI

Venkatakrishnan, Karthik; Liu, Yi; Noe, Dennis; Mertz, Jaime; Bargfrede, Michael; Marbury, Thomas; Farbakhsh, Kambiz; Oliva, Cristina; Milton, Ashley

Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2014-05-22

OAAI

Venkatakrishnan, Karthik; Liu, Yi; Noe, Dennis; Mertz, Jaime; Bargfrede, Michael; Marbury, Thomas; Farbakhsh, Kambiz; Oliva, Cristina; Milton, Ashley

Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2013-01-10

OAAI

Scott, Graham; Ahmad, Irfan; Howard, Katy; MacLean, David; Oliva, Cristina; Warrington, Steve; Wilbraham, Darren; Worthington, Paul

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Liposomal Mifamurtide (L-MTP-PE) in Adult Volunteers with Mild and Moderate Hepatic Impairment (HI)

EUROPEAN JOURNAL OF CANCER

IF7.1

2012-11-01

PREAI

Venkatakrishnan, K.; Liu, Y.; Noe, D.; Mertz, J.; Mockler, M.; Marbury, T.; Farbakhsh, K.; Oliva, C.; Milton, A.

COST-EFFECTIVENESS ANALYSIS OF BIO-HYALURONIC ACID (HA) IN PATIENTS WITH KNEE OSTEOARTHRITIS IN MEXICO

VALUE IN HEALTH

IF6

2011-11-01

OAAI

Aguirre, A.; Bierschwale, H.; Espinosa, F.; Michel, M.; Aguilera, J.; Esquivel, R.; Oliva, C.; Sierra, M.; Martinez, M.

Pharmacokinetics and Pharmacodynamics of Liposomal Mifamurtide in Patients With Osteosarcoma

EUROPEAN JOURNAL OF CANCER

IF7.1

2011-09-01

PREAI

Venkatakrishnan, K.; Meyers, P.; Mould, D. R.; Green, B.; Synold, T. W.; Oliva, C.; Anderson, P.

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer

ANNALS OF ONCOLOGY

IF65.4

2010-03-01

PREAI

Capri, G.; Chang, J.; Chen, S. -C.; Conte, P.; Cwiertka, K.; Jerusalem, G.; Jiang, Z.; Johnston, S.; Kaufman, B.; Link, J.; Ro, J.; Schuette, J.; Oliva, C.; Parikh, R.; Preston, A.; Rosenlund, J.; Selzer, M.; Zembryki, D.; De Placido, S.

Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin

CLINICAL CANCER RESEARCH

IF10.2

2009-05-18

PREAI

Rojo, Federico; Gonzalez-Navarrete, Irene; Bragado, Rafael; Dalmases, Alba; Menendez, Silvia; Cortes-Sempere, Maria; Suarez, Cristina; Oliva, Cristina; Servitja, Sonia; Rodriguez-Fanjul, Vanesa; Sanchez-Perez, Isabel; Campas, Clara; Maria Corominas, Josep; Tusquets, Ignasi; Bellosillo, Beatriz; Serrano, Sergi; Perona, Rosario; Rovira, Ana; Albanell, Joan

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

CLINICAL CANCER RESEARCH

IF10.2

2009-02-19

544

OAAI

Lin, Nancy U.; Dieras, Veronique; Paul, Devchand; Lossignol, Dominique; Christodoulou, Christos; Stemmler, Hans-Joachim; Roche, Henri; Liu, Minetta C.; Greil, Richard; Ciruelos, Eva; Loibl, Sibylle; Gori, Stefania; Wardley, Andrew; Yardley, Denise; Brufsky, Adam; Blum, Joanne L.; Rubin, Stephen D.; Dharan, Bernie; Steplewski, Klaudia; Zembryki, Denise; Oliva, Cristina; Roychowdhury, Debasish; Paoletti, Paolo; Winer, Eric P.

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer 转移性乳腺癌患者HER-2基因扩增、HER-2和表皮生长因子受体mRNA和蛋白表达及拉帕替尼疗效

CLINICAL CANCER RESEARCH

IF10.2

2008-12-01

162

OAAI

Press, Michael F.; Finn, Richard S.; Cameron, David; Di Leo, Angelo; Geyer, Charles E.; Villalobos, Ivonne E.; Santiago, Angela; Guzman, Roberta; Gasparyan, Armen; Ma, Yanling; Danenberg, Kathy; Martin, Anne Marie; Williams, Lisa; Oliva, Cristina; Stein, Steven; Gagnon, Robert; Arbushites, Michael; Koehler, Maria T.

Pooled analysis of diarrhea events in patients with cancer treated with lapatinib

BREAST CANCER RESEARCH AND TREATMENT

IF3

2008-01-20

PREAI

Crown, John P.; Burris, Harold A., III; Boyle, Fran; Jones, Suzanne; Koehler, Maria; Newstat, Beth O.; Parikh, Roma; Oliva, Cristina; Preston, Alaknanda; Byrne, Julie; Chan, Steve

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

BREAST CANCER RESEARCH AND TREATMENT

IF3

2008-01-11

663

PREAI

Cameron, David; Casey, Michelle; Press, Michael; Lindquist, Deborah; Pienkowski, Tadeusz; Romieu, C. Gilles; Chan, Stephen; Jagiello-Gruszfeld, Agnieszka; Kaufman, Bella; Crown, John; Chan, Arlene; Campone, Mario; Viens, Patrice; Davidson, Neville; Gorbounova, Vera; Raats, Johannes Isaac; Skarlos, Dimosthenis; Newstat, Beth; Roychowdhury, Debasish; Paoletti, Paolo; Oliva, Cristina; Rubin, Stephen; Stein, Steven; Geyer, Charles E.

研究方向